Clinical Research Directory

Inclusion Criteria: * Patients who participated in "Efficacy and safety study of autologous cardiac stem cells (JRM-001) treated after reconstructive surgery in pediatric patients with congenital heart disease" and meet the following criteria; * JRM-001 administration group: received JRM-001 investigational product after catheter examination * Non-administered group: underwent cardiac catheter examiniation only Exclusion Criteria: * Patients who is difficult to visit the clinical trial site * Patients who is difficult to obtain the provision of medical information from clinical institute to which the patient is transferred